Home
OrbiMed Capital GP VIII, 10% Owner: Traws Pharma TRAW Buy · Filed 04/28
Trade details
- Type
- Insider buy
- Amount
- $998,207.43
- Shares · price
- 597,729 sh · $1.67 a share
- Held after
- 1,203,250 sh
- Stock
- Traws Pharma TRAW
- Trade date
- 26/04/16
- Filed
- 26/04/28
- Days to filing
- 12 days
First buy since 2023
- Insiders buying this week
- 2 insiders
- Holding change
- +98.7%
Traws Pharma trades, last 26 weeks
What else happened in Traws Pharma around then
Filed or reported within 30 days of the trade day · 03/17~05/16OrbiMed Capital GP VIII's recent trades
- OrbiMed Capital GP VIII
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 planSionna Therapeutics
SION
$4,493
101 sh
$4,493
Filed 05/29
Traded 05/27
- OrbiMed Capital GP VIII
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 planSionna Therapeutics
SION
$8.5M
184,639 sh
$8.5M
Filed 05/11
Traded 05/11
- OrbiMed Capital GP VIII
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 planSionna Therapeutics
SION
$2.7M
59,767 sh
$2.7M
Filed 05/11
Traded 05/08
- OrbiMed Capital GP VIII
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 planSionna Therapeutics
SION
$2.2M
48,546 sh
$2.2M
Filed 05/11
Traded 05/07
- OrbiMed Capital GP VIII
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 planSionna Therapeutics
SION
$2.3M
52,397 sh
$2.3M
Filed 04/21
Traded 04/17